A quantitative assessment of nanoparticle-ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates.

Functional nanoparticles often contain ligands including targeting molecules, fluorophores, and/or active moieties such as drugs. Characterizing the number of these ligands bound to each particle and the distribution of nanoparticle-ligand species is important for understanding the nanomaterial's function. In this study, the amide coupling methods commonly used to conjugate ligands to poly(amidoamine) (PAMAM) dendrimers were examined. A skewed Poisson distribution was observed and quantified using HPLC for two sets of dendrimer-ligand samples prepared using the amine-terminated form of the PAMAM dendrimer and a partially acetylated form of the PAMAM dendrimer that has been used for targeted in vivo drug delivery. The prepared samples had an average number of ligands per dendrimer ranging from 0.4 to 13. Distributions identified by HPLC are in excellent agreement with the mean ligand/dendrimer ratio, measured by (1)H NMR, gel permeation chromatography (GPC), and potentiometric titration. These results provide insight into the heterogeneity of distributions that are obtained for many classes of nanomaterials to which ligands are conjugated and belie the use of simple cartoon models that present the "average" number of ligands bound as a physically meaningful representation for the material.

[1]  M. Colombo,et al.  Resolving the structure of ligands bound to the surface of superparamagnetic iron oxide nanoparticles by high-resolution magic-angle spinning NMR spectroscopy. , 2008, Journal of the American Chemical Society.

[2]  L. Sander,et al.  The implications of stochastic synthesis for the conjugation of functional groups to nanoparticles. , 2008, Bioconjugate chemistry.

[3]  K. Hamad-Schifferli,et al.  Structure and function of nanoparticle–protein conjugates , 2008, Biomedical materials.

[4]  M. Grinstaff,et al.  Therapeutic and diagnostic applications of dendrimers for cancer treatment. , 2008, Advanced drug delivery reviews.

[5]  K. Aschenbach,et al.  Systematic Aptamer-Gold Nanoparticle Colorimetry for Protein Detection: Thrombin , 2008, IEEE Sensors Journal.

[6]  Stefan Vogt,et al.  Synthesis, characterization, and in vitro testing of superparamagnetic iron oxide nanoparticles targeted using folic Acid-conjugated dendrimers. , 2008, ACS nano.

[7]  A. Alivisatos,et al.  Isolation of discrete nanoparticle-DNA conjugates for plasmonic applications. , 2008, Nano letters.

[8]  Eva Syková,et al.  Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling. , 2008, Bioconjugate chemistry.

[9]  Thommey P. Thomas,et al.  Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates , 2008, Anti-cancer drugs.

[10]  R. Maier,et al.  Mechanistic analysis of macrophage response to IRAK-1 gene knockdown by a smart polymer-antisense oligonucleotide therapeutic , 2008, Journal of biomaterials science. Polymer edition.

[11]  J. Baker,et al.  Synthetic PAMAM-RGD conjugates target and bind to odontoblast-like MDPC 23 cells and the predentin in tooth organ cultures. , 2007, Bioconjugate chemistry.

[12]  Ling Peng,et al.  Propagation of structural deviations of poly(amidoamine) fan-shape dendrimers (generations 0-3) characterized by MALDI and electrospray mass spectrometry , 2007 .

[13]  Thierry Gacoin,et al.  Counting the number of proteins coupled to single nanoparticles. , 2007, Journal of the American Chemical Society.

[14]  J. Baker,et al.  Dendrimer-based BH3 conjugate that targets human carcinoma cells. , 2007, Biomacromolecules.

[15]  Jianjun Cheng,et al.  Anticancer Polymeric Nanomedicines , 2007 .

[16]  S. Nie,et al.  Nanotechnology applications in cancer. , 2007, Annual review of biomedical engineering.

[17]  Erkki Ruoslahti,et al.  Targeted quantum dot conjugates for siRNA delivery. , 2007, Bioconjugate chemistry.

[18]  Prakash V Diwan,et al.  Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug delivery. , 2007, Journal of biomedical materials research. Part A.

[19]  R. Murray,et al.  Poly(ethylene glycol) ligands for high-resolution nanoparticle mass spectrometry. , 2007, Journal of the American Chemical Society.

[20]  J. Bacri,et al.  Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. , 2007, Journal of the American Chemical Society.

[21]  Igor L. Medintz,et al.  Solution-phase single quantum dot fluorescence resonance energy transfer. , 2006, Journal of the American Chemical Society.

[22]  Swarnlata Saraf,et al.  Nanocarriers: promising vehicle for bioactive drugs. , 2006, Biological & pharmaceutical bulletin.

[23]  Seungpyo Hong,et al.  HPLC analysis of functionalized poly(amidoamine) dendrimers and the interaction between a folate-dendrimer conjugate and folate binding protein. , 2006, The Analyst.

[24]  Wolfgang J. Parak,et al.  Electrophoretic Separation of Nanoparticles with a Discrete Number of Functional Groups , 2006 .

[25]  L. Köhidai,et al.  Synthesis of oligotuftsin‐based branched oligopeptide conjugates for chemotactic drug targeting , 2006, Journal of peptide science : an official publication of the European Peptide Society.

[26]  Thommey P. Thomas,et al.  PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. , 2006, Biomacromolecules.

[27]  Francis C Szoka,et al.  Designing dendrimers for biological applications , 2005, Nature Biotechnology.

[28]  Thommey P. Thomas,et al.  Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates. , 2005, Chemical communications.

[29]  C. Hawker,et al.  Multivalent, bifunctional dendrimers prepared by click chemistry. , 2005, Chemical communications.

[30]  J. Sessler,et al.  Gadolinium texaphyrin-methotrexate conjugates. Towards improved cancer chemotherapeutic agents. , 2005, Organic & biomolecular chemistry.

[31]  Thommey P. Thomas,et al.  Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. , 2005, Journal of medicinal chemistry.

[32]  K. Jain,et al.  Nanotechnology in clinical laboratory diagnostics. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[33]  Thommey P. Thomas,et al.  Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. , 2005, Cancer research.

[34]  Thommey P. Thomas,et al.  Targeting and inhibition of cell growth by an engineered dendritic nanodevice. , 2005, Journal of medicinal chemistry.

[35]  Thommey P. Thomas,et al.  Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy. , 2004, Bioconjugate chemistry.

[36]  M. Green,et al.  Folate-receptor-targeted radionuclide imaging agents. , 2004, Advanced drug delivery reviews.

[37]  R. Weissleder,et al.  Surface‐Functionalized Nanoparticle Library Yields Probes for Apoptotic Cells , 2004, Chembiochem : a European journal of chemical biology.

[38]  Bradford G. Orr,et al.  DNA-Directed Synthesis of Generation 7 and 5 PAMAM Dendrimer Nanoclusters , 2004 .

[39]  Ralph Weissleder,et al.  A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. , 2003, Cancer research.

[40]  I. Majoros,et al.  Acetylation of Poly(amidoamine) Dendrimers , 2003 .

[41]  Mary J Cloninger,et al.  Biological applications of dendrimers. , 2002, Current opinion in chemical biology.

[42]  P. Wils,et al.  Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors , 2002, Gene Therapy.

[43]  Thommey P. Thomas,et al.  Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells Through the Folate Receptor , 2002, Pharmaceutical Research.

[44]  Anil K Patri,et al.  Dendritic polymer macromolecular carriers for drug delivery. , 2002, Current opinion in chemical biology.

[45]  C. Mirkin,et al.  Array-Based Electrical Detection of DNA with Nanoparticle Probes , 2002, Science.

[46]  R Weissleder,et al.  High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. , 1999, Bioconjugate chemistry.

[47]  Richard D. Smith,et al.  Electrospray ionization Fourier transform ion cyclotron resonance mass spectrometric characterization of high molecular mass Starburst™ dendrimers , 1997 .

[48]  P. Low,et al.  Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging. , 1996, Bioconjugate chemistry.

[49]  M. Singh,et al.  Synthesis of methotrexate-antibody conjugates by regiospecific coupling and assessment of drug and antitumor activities. , 1989, Journal of medicinal chemistry.

[50]  D. Tomalia,et al.  Improved methodology for monitoring poly(amidoamine) dendrimers surface transformations and product quality by ultra performance liquid chromatography , 2008 .

[51]  Prakash V Diwan,et al.  The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats. , 2007, Biomaterials.

[52]  Thommey P. Thomas,et al.  Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting. , 2005, Chemistry & biology.

[53]  J. Fréchet,et al.  Dendrimers and dendritic polymers in drug delivery. , 2005, Drug discovery today.

[54]  M. Chatterjee,et al.  Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy. , 2004, Bioconjugate chemistry.

[55]  J. Subbi,et al.  Structural deviations in poly(amidoamine) dendrimers: a MALDI-TOF MS analysis , 2003 .

[56]  R. Roy,et al.  Synthesis and protein binding properties of T-antigen containing GlycoPAMAM dendrimers. , 2002, Bioorganic & medicinal chemistry.

[57]  A. Rosowsky,et al.  Regiospecific gamma-conjugation of methotrexate to poly(L-lysine). Chemical and biological studies. , 1985, Molecular pharmacology.

[58]  Seungpyo Hong,et al.  The Binding Avidity of a Nanoparticle-based Multivalent Targeted Drug Delivery Platform , 2022 .